The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Gilead Sciences (NASDAQ:GILD).
The investment seeks capital appreciation.
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
The average market capitalization across the Fidelity® Select Pharmaceuticals Port MF is 180.25B. The market cap for tickers in the group ranges from 2.45B to 516.84B. LLY holds the highest valuation in this group at 516.84B. The lowest valued company is ROG at 2.45B.
The average weekly volume growth across all stocks in the Fidelity® Select Pharmaceuticals Port MF was -8%. For the same stocks of the MF, the average monthly volume growth was -7% and the average quarterly volume growth was -5%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 19
P/E Growth Rating: 46
Price Growth Rating: 52
SMR Rating: 49
Profit Risk Rating: 33
Seasonality Score: -19 (-100 ... +100)